Nuwellis, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated June 5, 2024, covers two critical events for Nuwellis, Inc. (NUWE): a notice of potential delisting from the Nasdaq Capital Market and the results of the Annual Meeting of Stockholders held on June 6, 2024.
Key Financial Metrics
The filing does not provide specific revenue, profit, cash flow, or margin data. However, it highlights significant capital structure and listing compliance issues:
- Stock Price: The closing bid price has remained below $1.00 per share for 30 consecutive trading days, triggering non-compliance with Nasdaq Rule 5550(a)(2).
- Stockholders' Equity: The company previously failed to meet the $5,000,000 minimum stockholders' equity requirement for initial listing and was notified on May 29, 2024, of non-compliance with the $2.5 million minimum stockholders' equity requirement for continued listing.
- Share Count: Approximately 2,776,399 shares were present at the Annual Meeting, representing roughly 41% of outstanding shares.
Material Changes and Events
Delisting Notice: On June 5, 2024, Nasdaq notified Nuwellis that it has not regained compliance with the Minimum Bid Price Requirement. Due to prior failures to meet stockholders' equity requirements, the company is not eligible for a second 180-day compliance period. Unless the company appeals and the appeal is successful, the stock faces delisting.
Reverse Stock Split Approval: At the Annual Meeting, stockholders approved an amendment to the Certificate of Incorporation to effect a reverse stock split at a ratio between 1-for-5 and 1-for-70. This action is intended to raise the share price to comply with Nasdaq listing standards.
Outlook, Risks, and Management Commentary
Appeal Process: Management intends to request a hearing before the Nasdaq Hearings Panel by June 12, 2024. This request will automatically stay any delisting action pending the Panel's decision. The company plans to submit a compliance plan to the Panel.
Risks: There is no assurance that the Panel will grant a request for continued listing or that the company will regain compliance within any granted timeframe. The filing explicitly states there can be no assurance the company will remain listed on Nasdaq.
Corporate Actions: Stockholders also approved the ratification of Baker Tilly US, LLP as the independent auditor, advisory votes on executive compensation (every three years), and anti-dilution provisions for warrants issued in April 2024.
Investor Verification Checklist
- Verify the specific reverse stock split ratio (1-for-5 to 1-for-70) once determined by the Board of Directors.
- Monitor the outcome of the Nasdaq Hearings Panel regarding the delisting appeal.
- Review the company's plan to address the $2.5 million stockholders' equity deficiency.
- Confirm the effective date of the reverse stock split and the impact on share count and price.
- Check for any subsequent filings regarding the status of the Nasdaq listing.